TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.980
-0.030 (-0.75%)
Nov 4, 2024, 4:00 PM EST - Market closed
TriSalus Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 121 | 222 | 313 | 309 | - |
| Market Cap Growth | 93.45% | -29.05% | 1.52% | - | - |
| Enterprise Value | 128 | 203 | 407 | - | - |
| Last Close Price | 3.98 | 8.45 | 10.03 | 9.88 | - |
| PE Ratio | - | -1.25 | -0.06 | -3.04 | - |
| PS Ratio | 3.38 | 12.01 | 25.28 | 36.75 | - |
| PB Ratio | -6.21 | -8.57 | -25.43 | 9.99 | - |
| P/FCF Ratio | -2.71 | -4.39 | -9.51 | -12.98 | - |
| P/OCF Ratio | -2.75 | -4.44 | -9.70 | -13.60 | - |
| EV/Sales Ratio | 5.16 | 10.95 | 32.84 | - | - |
| EV/EBITDA Ratio | -2.85 | -3.79 | -11.30 | - | - |
| EV/EBIT Ratio | -2.81 | -3.74 | -11.17 | - | - |
| EV/FCF Ratio | -2.67 | -4.00 | -12.35 | - | - |
| Debt / Equity Ratio | -0.94 | -0.06 | -0.16 | - | -0.84 |
| Debt / FCF Ratio | -0.41 | -0.03 | -0.06 | - | -2.62 |
| Asset Turnover | 1.00 | 0.78 | 0.41 | 0.37 | - |
| Inventory Turnover | 1.23 | 1.30 | 1.63 | 1.28 | - |
| Quick Ratio | 1.77 | 1.04 | 0.34 | 4.97 | 0.09 |
| Current Ratio | 2.33 | 1.42 | 0.53 | 5.51 | 0.11 |
| Return on Equity (ROE) | - | - | -507.96% | - | - |
| Return on Assets (ROA) | -133.15% | -141.84% | -76.13% | -65.35% | - |
| Return on Capital (ROIC) | - | - | -221.73% | -131.01% | - |
| Earnings Yield | -47.14% | -26.55% | -15.05% | -9.34% | - |
| FCF Yield | -45.55% | -22.77% | -10.52% | -7.71% | - |
| Buyback Yield / Dilution | -15.73% | -2934.71% | 96.51% | -15.52% | - |
| Total Shareholder Return | -15.73% | -2934.71% | 96.51% | -15.52% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.